NYSE: TAP

MOLSON COORS BEVERAGE CO

CIK 0000024545 · Consumer Staples · SIC 2082 · Malt Beverages

Mega Revenue $13.0B Assets $22.7B as of Jul 19, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (RBLX 10-Q) is open in full — no account needed.

8-K Filed Jun 24, 2026 · Period ending Jun 24, 2026

Molson Coors EMEA&APAC President takes medical leave; UK chief named interim leader

2 material changes detected. Sign up free to read the summary.

8-K Filed May 27, 2026 · Period ending May 27, 2026

Molson Coors raises $1.85B in senior notes to refinance 2026 debt at higher rates

4 material changes detected. Sign up free to read the summary.

Partner

Trade TAP commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B5 Filed May 22, 2026

Molson Coors prices $1.5B debt offering: $500M 4.900% 2031 notes, $1B 5.500% 2036 notes

4 material changes detected. Sign up free to read the summary.

8-K Filed May 22, 2026 · Period ending May 20, 2026

Molson Coors raises in dual-currency debt offering across U.S. and Canada

4 material changes detected. Sign up free to read the summary.

8-K Filed May 8, 2026 · Period ending May 6, 2026

Molson Coors shareholders elect all directors, approve executive pay at annual meeting

3 material changes detected. Sign up free to read the summary.

10-Q Filed Apr 30, 2026 · Period ending Mar 31, 2026

Molson Coors posts 2% sales growth but faces $30M aluminum cost hit and market share losses

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 30, 2026 · Period ending Apr 30, 2026

Molson Coors reports Q1 2026 financial results in earnings release

2 material changes detected. Sign up free to read the summary.

10-K Filed Feb 18, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 4, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed May 8, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Feb 18, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Apr 30, 2026 (period ending Mar 31, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations (Unaudited)

Description Q1 ended Mar 31, 2025 Q3 ended Sep 30, 2025
Revenue:
Total revenue / net sales 2,690 3,484
Cost of revenue / cost of sales 1,453 1,800
Gross profit 850.9 1,174
Operating expenses:
Sales and marketing 286.1 366.5
Selling, general and administrative 653.2 686.7
Other operating expenses, net 111.4 4,062
Operating income 186.3 (3,431)
Interest expense 61.3 62.7
Other income/(expense), net (30.0) (64.4)
Income before income taxes 156.3 (3,496)
Income tax expense/(benefit) 33.2 (558.6)
Net income 121.0 (2,928)
Basic earnings per share 0.60 (14.79)
Diluted earnings per share 0.59 (14.79)

Consolidated Balance Sheets (Unaudited)

Description Mar 31, 2025 Sep 30, 2025
Current assets:
Cash and equivalents 412.7 950.2
Accounts receivable, net 789.1 842.5
Inventories 345.1 304.9
Prepaid expenses and other current assets 371.4 465.8
Other current assets 645.3 667.0
Total current assets 2,564 3,230
Operating lease right-of-use assets, net 196.9 196.9
Identifiable intangible assets, net 12,204 12,015
Goodwill 5,582 1,944
Deferred income taxes and other assets 1,075 1,058
Other long-term assets 4,309 4,430
TOTAL ASSETS 25,930 22,873
Current liabilities:
Current portion of long-term debt 11.6 2,371
Current portion of operating lease liabilities 53.4 54.5
Other current liabilities 2,801 2,920
Total current liabilities 2,866 5,345
Long-term debt 6,155 3,885
Operating lease liabilities 166.7 163.3
Deferred income taxes and other liabilities 2,738 2,243
Other long-term liabilities 553.3 568.8
Total liabilities 12,479 12,205
Redeemable preferred stock 165.8 145.5
Shareholders' equity:
Capital in excess of stated value 7,223 7,240
Accumulated other comprehensive income (loss) (1,325) (1,145)
Retained earnings (deficit) 8,263 5,576
Treasury stock 1,441 1,716
Total shareholders' equity 13,090 10,325
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 25,930 22,873

Consolidated Statements of Cash Flows (Unaudited)

Description Q1 ended Mar 31, 2025 Nine months ended Sep 30, 2025
Operating Activities:
Net cash from operating activities (90.7) 1,244
Investing Activities:
Net cash from investing activities (341.3) (635.1)
Financing Activities:
Net cash from financing activities (131.2) (646.6)
Net increase/(decrease) in cash (556.6) (19.1)

Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗

View AI report for this filing